Becton Dickinson (BDX) Stock Sees 6% Rise After Earnings Beat
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowBecton, Dickinson and Company (NYSE: BDX) experienced a nearly 6% increase in stock price following a strong earnings report on May 7. The company raised its full-year earnings forecast, highlighting excellent execution across its medical supply and technology divisions. Jim Cramer noted this was the lowest valuation level he has seen for the stock, suggesting potential further upside. Despite near-term challenges from increased AI spending, BDX's positive earnings reflect strong operational performance and market positioning.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Becton Dickinson and Company (BDX)
Becton Dickinson is a major maker of medical supplies and devices.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier BDX news
BDX stock page and all news →Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Chinese Equities See Earnings Forecasts Fall Amid Prolonged Downturn
Oct 25
Climb Bio Reports Early Trial Data on Budoprutug for Kidney Diseases
Oct 24
Trade Desk (TTD) CEO Overrides Investor Opposition to Option Repricing
Oct 24
iShares Biotech ETF (IBB) Surges 24% Year-To-Date Amid Moderna's 587% Gain
Oct 24